AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 171 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1 | -100.0% | 205,500 | 0.0% | 0.00% | -100.0% |
Q3 2022 | $36,000 | -82.7% | 205,500 | 0.0% | 0.00% | -80.0% |
Q2 2022 | $208,000 | -41.6% | 205,500 | -8.9% | 0.01% | -33.3% |
Q1 2022 | $356,000 | -82.1% | 225,500 | -14.5% | 0.02% | -72.2% |
Q4 2021 | $1,992,000 | -12.8% | 263,600 | -2.8% | 0.05% | -28.0% |
Q3 2021 | $2,284,000 | +205.3% | 271,200 | +4.6% | 0.08% | +226.1% |
Q2 2021 | $748,000 | +1016.4% | 259,300 | +305.8% | 0.02% | +475.0% |
Q1 2021 | $67,000 | -95.6% | 63,900 | -87.5% | 0.00% | -90.7% |
Q4 2020 | $1,508,000 | -15.0% | 509,956 | +5.6% | 0.04% | -50.6% |
Q3 2020 | $1,774,000 | +5622.6% | 482,947 | +4456.1% | 0.09% | +4250.0% |
Q2 2020 | $31,000 | -97.9% | 10,600 | -96.8% | 0.00% | -98.0% |
Q1 2020 | $1,499,000 | +85.7% | 326,240 | +339.3% | 0.10% | +120.0% |
Q4 2019 | $807,000 | +8866.7% | 74,270 | +642.7% | 0.04% | – |
Q2 2017 | $9,000 | -80.0% | 10,000 | -93.6% | 0.00% | -100.0% |
Q1 2017 | $45,000 | -57.5% | 157,100 | +15.9% | 0.00% | -40.0% |
Q4 2016 | $106,000 | – | 135,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 188,500 | $4,311,000 | 3.12% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 334,500 | $7,647,000 | 1.70% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 131,760 | $3,013,000 | 1.49% |
NEA Management Company, LLC | 3,069,834 | $70,207,000 | 1.42% |
Berry Street Capital Management LLP | 575,000 | $13,151,000 | 1.36% |
Melqart Asset Management (UK) Ltd | 916,321 | $20,956,000 | 1.06% |
SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $2,287,000 | 0.93% |
HighMark Wealth Management LLC | 50,499 | $1,155,000 | 0.73% |
Artal Group S.A. | 1,000,000 | $22,870,000 | 0.62% |
Vigilare Wealth Management | 34,925 | $799,000 | 0.47% |